11/05/2021
Inspecting clinical trial sites can be especially resource-intensive and onerous for sponsors as well as the clinical research associates (CRAs) responsible for executing this process.
This article will outline an industry-first approach to reducing the travel burden and the associated time and costs: https://bit.ly/3mBat6V